(Approval lapsed) BCG 10 Anti-Tuberculosis Vaccine powder and solvent for suspension for intradermal injections (0.5 mg (from 1.5 mln to 6 mln) of live BCG bacilli (Bacillus Calmette-Guerin), the Brazilian Moreau Substrain)
Section 19A approved medicine
(Approval lapsed) BCG 10 Anti-Tuberculosis Vaccine powder and solvent for suspension for intradermal injections (0.5 mg (from 1.5 mln to 6 mln) of live BCG bacilli (Bacillus Calmette-Guerin), the Brazilian Moreau Substrain)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
BCG VACCINE Mycobacterium bovis (Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) (BCG) strain) 1.5mg powder for injection multidose vial with diluent vial - ARTG 53569
Indication(s)
BCG 10 Anti-Tuberculosis Vaccine is recommended for active immunisation in high risk groups.
Additional information
Link Medical Products has advised the TGA that BCG 10 Anti-Tuberculosis Vaccine is currently unavailable. Healthcare professionals may wish to consider using an alternative product under the Special Access Scheme or Authorised Prescriber pathways.